Literature DB >> 24338706

Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia.

Simone Cesaro1, Paola De Filippi, Annamaria Di Meglio, Anna Leszl, Svetlana Donska, Ada Zaccaron, Claudia Cagioni, Roberta Galavotti, Cesare Danesino, Fiorenza Aprili, Chiara Cugno, Geertruy te Kronnie, Marco Zecca, Silvia Bresolin.   

Abstract

A twin pair affected by juvenile myelomonocytic leukemia (JMML) with the same somatic PTPN11 mutation and abnormal chromosome 7 in bone marrow samples but distinct prognostic gene expression signatures, received a matched-unrelated donor and matched-unrelated cord blood transplant, respectively. Both twins fully engrafted, but after 6 months, the twin with an acute-myeloid-like (AML-like) signature at diagnosis rejected the graft and had an autologous reconstitution. A second transplant with an unrelated 5/6-HLA-matched-loci cord blood performed after 4 months from rejection was unsuccessful. After 25 months from diagnosis, the twin with the AML-like gene expression signature died of liver failure while on progression of his JMML. The other twin, who had a non-acute-myeloid-like (non-AML-like) gene expression signature at diagnosis is in complete hematological remission with full donor chimera. This observation suggests a biological diversity of JMML also in patients with a common genetic background.

Entities:  

Mesh:

Year:  2013        PMID: 24338706     DOI: 10.1007/s12185-013-1489-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.

Authors:  Rebecca J Chan; Todd Cooper; Christian P Kratz; Brian Weiss; Mignon L Loh
Journal:  Leuk Res       Date:  2008-10-26       Impact factor: 3.156

2.  Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.

Authors:  Hirotoshi Sakaguchi; Yusuke Okuno; Hideki Muramatsu; Kenichi Yoshida; Yuichi Shiraishi; Mariko Takahashi; Ayana Kon; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Hideki Makishima; Xinan Wang; Yinyan Xu; Sayoko Doisaki; Asahito Hama; Koji Nakanishi; Yoshiyuki Takahashi; Nao Yoshida; Jaroslaw P Maciejewski; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330

Review 3.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

4.  Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.

Authors:  Silvia Bresolin; Marco Zecca; Christian Flotho; Luca Trentin; Andrea Zangrando; Laura Sainati; Jan Stary; Barbara de Moerloose; Henrik Hasle; Charlotte M Niemeyer; Geertruy Te Kronnie; Franco Locatelli; Giuseppe Basso
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

5.  Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.

Authors:  Reo Tanoshima; Hiroaki Goto; Masakatsu Yanagimachi; Ryosuke Kajiwara; Fumiko Kuroki; Shumpei Yokota
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

6.  Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system.

Authors:  S J Passmore; I M Hann; C A Stiller; P Ramani; G J Swansbury; B Gibbons; B R Reeves; J M Chessells
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

7.  Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival.

Authors:  S Jane Passmore; Judith M Chessells; Helena Kempski; Ian M Hann; Pat A Brownbill; Charles A Stiller
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 8.  Pre-natal origins of childhood leukemia.

Authors:  Mel Greaves
Journal:  Rev Clin Exp Hematol       Date:  2003-09

9.  Molecular targets for the treatment of juvenile myelomonocytic leukemia.

Authors:  Xiaoling Liu; Himalee Sabnis; Kevin D Bunting; Cheng-Kui Qu
Journal:  Adv Hematol       Date:  2011-11-13

10.  The risk of cancer in twins: a report from the childhood cancer survivor study.

Authors:  Nina S Kadan-Lottick; Toana Kawashima; Gail Tomlinson; Debra L Friedman; Yutaka Yasui; Ann C Mertens; Leslie L Robison; Louise C Strong
Journal:  Pediatr Blood Cancer       Date:  2006-04       Impact factor: 3.838

View more
  3 in total

1.  Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Tali Mazor; Adam B Olshen; Huimin Geng; Laura C Gelston; Jon Akutagawa; Daniel B Lipka; Christoph Plass; Christian Flotho; Farid F Chehab; Benjamin S Braun; Joseph F Costello; Mignon L Loh
Journal:  Nat Commun       Date:  2017-12-19       Impact factor: 14.919

2.  Research on the effect of ginseng polysaccharide on apoptosis and cell cycle of human leukemia cell line K562 and its molecular mechanisms.

Authors:  Wei Xiong; Jing Li; Rong Jiang; Danyang Li; Zehong Liu; Dilong Chen
Journal:  Exp Ther Med       Date:  2017-01-24       Impact factor: 2.447

Review 3.  Mini-review of kidney disease following hematopoietic stem cell transplant
.

Authors:  Ramy Sedhom; Daniel Sedhom; Edgar Jaimes
Journal:  Clin Nephrol       Date:  2018-06       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.